These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 32849827)

  • 21. Cell-free nucleic acids as potential markers for preeclampsia.
    Hahn S; Rusterholz C; Hösli I; Lapaire O
    Placenta; 2011 Feb; 32 Suppl():S17-20. PubMed ID: 21257079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs.
    Mansueto G; Benincasa G; Della Mura N; Nicoletti GF; Napoli C
    J Clin Pathol; 2020 Sep; 73(9):535-543. PubMed ID: 32616540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating nucleic acids: An analysis of their occurrence in malignancies.
    Suraj S; Dhar C; Srivastava S
    Biomed Rep; 2017 Jan; 6(1):8-14. PubMed ID: 28123700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
    Ferracin M; Lupini L; Mangolini A; Negrini M
    Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
    Jankowska AM; Millward CL; Caldwell CW
    Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating nucleic acids in plasma and serum: recent developments.
    Swaminathan R; Butt AN
    Ann N Y Acad Sci; 2006 Sep; 1075():1-9. PubMed ID: 17108186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow the trace of death: methylation analysis of cell-free DNA for clinical applications in non-cancerous diseases.
    Tost J
    Epigenomics; 2016 Sep; 8(9):1169-72. PubMed ID: 27529647
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma.
    Moonmuang S; Chaiyawat P; Jantrapirom S; Pruksakorn D; Lo Piccolo L
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Imaging of Epigenetic Modifications in Cancer: A Systematic Review.
    Du Y; Zhang P; Liu W; Tian J
    Phenomics; 2022 Apr; 2(2):88-101. PubMed ID: 36939779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
    Kerachian MA; Poudineh A; Thiery JP
    Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidation of Epigenetic Landscape in Coronary Artery Disease: A Review on Basic Concept to Personalized Medicine.
    Sumi MP; Mahajan B; Sattar RSA; Nimisha ; Apurva ; Kumar A; Sharma AK; Ahmad E; Ali A; Saluja SS
    Epigenet Insights; 2021; 14():2516865720988567. PubMed ID: 33598635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.
    Tóth K; Barták BK; Tulassay Z; Molnár B
    Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application status of circulating nucleic acids as biomarkers in gastric cancer].
    Li L; Zhang L; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):21-5. PubMed ID: 24519044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine.
    Hamamoto R; Komatsu M; Takasawa K; Asada K; Kaneko S
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis.
    Bottani M; Banfi G; Lombardi G
    Front Genet; 2019; 10():1044. PubMed ID: 31737038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and Application of 5-Formylcytosine and 5-Formyluracil in DNA.
    Wang Y; Zhang X; Zou G; Peng S; Liu C; Zhou X
    Acc Chem Res; 2019 Apr; 52(4):1016-1024. PubMed ID: 30666870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications.
    Khan IN; Ullah N; Hussein D; Saini KS
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):85-102. PubMed ID: 28774835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating epigenetic biomarkers in melanoma.
    Xin Y; Li Z; Chan MT; Wu WK
    Tumour Biol; 2016 Feb; 37(2):1487-92. PubMed ID: 26662802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.